Companies / Slovenia
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
Krka Maintains Positive Outlook
February 2007 | Company Finance AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
On the back of impressive 2006 financial results, Slovenian drugmaker Krka is looking to further penetrate emerging markets, continue to upscale its R&D capabilities, get more products approved and invest in infrastructure to ensure future growth.